Abstract Background and Purpose Inflammation plays a crucial role in brain damage
following stroke. Here, we evaluate interleukin 23 (IL-23) and interleukin 17 (IL-17) in the …

Background The aim of this study is to investigate the associations between post-stroke
cognitive impairment (PSCI) severity and reactive astrogliosis (RA) extent on normalized 18 …

Ischemic stroke is a major cause of death and disability worldwide. Translation into the
clinical setting of neuroprotective agents showing promising results in pre-clinical studies …

Purpose Ischemic penumbra is the main therapeutic target for acute ischemic stroke. The
aim in this study is to investigate the potential serum biomarkers of penumbra that could …

Abstract Background The 18 F-THK-5351 radiotracer has been used to detect the in vivo tau
protein distribution in patients with tauopathy, such as Alzheimer's disease and corticobasal …

Ischemic stroke ranks among the foremost clinical causes of mortality and disability,
instigating neuronal degeneration, fatalities, and various sequelae. While standard …

Several mechanisms are involved in the loss of cellular integrity and tissue destructions in
various brain regions during ischemic insult. The affected brain employs various self-repair …

Introduction: Natalizumab, a well-characterized treatment for multiple sclerosis, is a
humanized antibody against alpha-4 integrin (CD49d) that mitigates the transmigration of …

Background Stroke is the third leading cause of death and leading cause of adult disability
worldwide. Long-term disability is a significant problem among survivors; post-stroke …

Background and aims Thrombolytic therapy is widely used to treat acute ischemic stroke
(AIS) patients. As intracerebral hemorrhage is a life‐threatening complication of this therapy …